dacarbazine has been researched along with Carcinoma, Papillary in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Licitra, L; Locati, LD | 1 |
Dixit, S; Hingorani, M; Rajaraman, C; Rowland-Hill, C; Salvage, D | 1 |
Donovski, L; Kumanov, Kh; Ormanov, I; Panchev, P; Tsvetkov, M | 1 |
3 other study(ies) available for dacarbazine and Carcinoma, Papillary
Article | Year |
---|---|
Multikinase inhibitors in thyroid cancer.
Topics: Adenocarcinoma, Follicular; Carcinoma, Medullary; Carcinoma, Neuroendocrine; Carcinoma, Papillary; Clinical Trials as Topic; Dacarbazine; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Iodine Isotopes; Molecular Targeted Therapy; Multiple Endocrine Neoplasia Type 2a; Neoplasm Metastasis; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Thyroid Neoplasms | 2012 |
Hypernatremia-associated myelinolysis following the management of sepsis in a patient with glioblastoma treated with radiotherapy and temozolomide.
Topics: Antineoplastic Agents; Brain Diseases; Brain Neoplasms; Carcinoma; Carcinoma, Papillary; Dacarbazine; Diabetes Mellitus; Fatal Outcome; Glioblastoma; Humans; Hypernatremia; Hypertension; Liver Diseases; Male; Middle Aged; Neoplasms, Second Primary; Radiotherapy, Conformal; Sepsis; Temozolomide; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2013 |
[Cases of the regression of advanced bladder tumors (T2-T4) after the use of chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Care; Remission Induction; Urinary Bladder Neoplasms; Vinblastine | 1990 |